All Stories

  1. Machine Learning Identifies Plasma Metabolites Associated With Heart Failure in Underrepresented Populations With the TTR V122I Variant

    Article • Journal of the American Heart Association, April 2023, Wolters Kluwer Health

    Joshua K. Park

  2. An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis

    Article • Advanced Science, April 2023, Wiley

    Joshua K. Park

  3. Phenome-wide Mendelian Randomization of Triglycerides and 2600 Diseases

    Article • eLife, March 2023, eLife

    Joshua K. Park

  4. Peripheral Hybrid CB1R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis

    Article • Frontiers in Endocrinology, September 2021, Frontiers

    Joshua K. Park

  5. CB 1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

    Article • Clinical and Translational Medicine, July 2021, Wiley

    Joshua K. Park

  6. The Heterogeneity of Lipid Metabolism in Cancer

    Article • January 2021, Springer Science + Business Media

    Joshua K. Park

  7. Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice

    Article • Nature Chemical Biology, May 2020, Springer Science + Business Media

    Dr Resat Cinar, Joshua K. Park

  8. Bleomycin Induces Drug Efflux in Lungs: A pitfall for Pharmacological Studies of Pulmonary Fibrosis

    Article • American Journal of Respiratory Cell and Molecular Biology, August 2019, American Thoracic Society

    Dr Resat Cinar, Joshua K. Park

  9. Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis

    Article • Cell Metabolism, June 2019, Elsevier

    Joshua K. Park

  10. The Heterogeneity of Lipid Metabolism in Cancer

    Article • January 2018, Springer Science + Business Media

    Joshua K. Park

  11. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy

    Article • Diabetes Obesity and Metabolism, December 2017, Wiley

    Dr. Janos Paloczi, Joshua K. Park, Dr Resat Cinar

  12. Network analyses identify liver‐specific targets for treating liver diseases

    Article • Molecular Systems Biology, August 2017, EMBO

    Professor Adil Mardinoglu, Sunjae Lee, Tim Kuijpers, Joshua K. Park, Dr Resat Cinar, Professor Morten Grötli

  13. Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis

    Article • JCI Insight, April 2017, American Society for Clinical Investigation

    Joshua K. Park, Dr Resat Cinar

  14. Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes

    Article • Diabetes, January 2017, American Diabetes Association

    Joshua K. Park, Dr Resat Cinar

  15. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

    Article • Proceedings of the National Academy of Sciences, August 2016, Proceedings of the National Academy of Sciences

    Joshua K. Park

  16. Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis

    Article • JCI Insight, July 2016, American Society for Clinical Investigation

    Joshua K. Park

  17. Glucose-Independent Glutamine-Driven TCA Cycle in Cancer Cells

    Article • November 2014, Springer Science + Business Media

    Joshua K. Park

  18. Abstract 852: Novel role and mechanism of the LDHA protein as a survival factor for cancer cells.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Joshua K. Park